PTGS2 and gastric cancer: They reported that 18βGA reduced the genesis and progression of gastric cancer by improving inflammatory events, as it downregulates cyclooxygenase-2 (COX-2) expression and Wnt-1 expression and upregulates tumor suppressor miR-149-3p.